Globus Medical (GMED) — insider trading
Health Care
Globus Medical (GMED) has 19 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 19 (latest 2026-06-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Davidar David D | Director | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-06-05 | Davidar David D | Director | Open-market sale | 25,000 | $80.76 | $2.02M | Form 4 |
| 2026-06-05 | Davidar David D | Director | Option exercise / conversion | 25,000 | $26.27 | $656.8K | Form 4 |
| 2026-06-04 | RHOADS ANN D | Director | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-06-04 | RHOADS ANN D | Director | Option exercise / conversion | 25,000 | $26.27 | $656.8K | Form 4 |
| 2026-02-25 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Option exercise / conversion (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-02-25 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Open-market sale | 20,000 | $94.50 | $1.89M | Form 4 |
| 2026-02-25 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Option exercise / conversion | 20,000 | $43.58 | $871.6K | Form 4 |
| 2026-02-12 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Option exercise / conversion (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Open-market sale | 10,000 | $87.67 | $876.7K | Form 4 |
| 2026-02-12 | Huller Kelly | Officer (EVP, GC, Corporate Secretary) | Option exercise / conversion | 10,000 | $45.64 | $456.4K | Form 4 |
| 2026-01-21 | TOBIN JAMES R | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | RHOADS ANN D | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Lemaitre Dan | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Douglas Robert Andrew | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Paul David C | Director, Officer (Executive Chairman), 10% owner | Grant / award / vesting (derivative) | 100,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Kline Kyle | Officer (Senior Vice President, CFO) | Grant / award / vesting (derivative) | 30,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Pfeil Keith W | Director, Officer (President, CEO) | Grant / award / vesting (derivative) | 100,000 | $0.00 | $0 | Form 4 |
| 2026-01-21 | Norwalk Leslie V | Director | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
Ask the chat about GMED's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Globus Medical (GMED).
Last updated 2026-06-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.